FORMOTEROL
Drug
Chiesi USA, Inc.
Total Payments
$59,338
Transactions
14
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $59,338 | 14 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $59,338 | 14 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CCD-05993AA3-03 | Chiesi USA, Inc. | $59,338 | 0 |
Top Doctors Receiving Payments for FORMOTEROL
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Los Angeles, CA | $59,338 | 14 |
Ad
Manufacturing Companies
- Chiesi USA, Inc. $59,338
Product Information
- Type Drug
- Total Payments $59,338
- Total Doctors 0
- Transactions 14
About FORMOTEROL
FORMOTEROL is a drug associated with $59,338 in payments to 0 healthcare providers, recorded across 14 transactions in the CMS Open Payments database. The primary manufacturer is Chiesi USA, Inc..
Payment data is available from 2017 to 2017. In 2017, $59,338 was paid across 14 transactions to 0 doctors.
The most common payment nature for FORMOTEROL is "Unspecified" ($59,338, 100.0% of total).
FORMOTEROL is associated with 1 research study, including "CCD-05993AA3-03" ($59,338).